ESOP Consultant in Hyderabad: A Complete Guide for Telangana Businesses

Published by Marcken Consulting LLP

Hyderabad has become one of India’s two largest Global Capability Centre hubs, anchored by HITEC City, Gachibowli and the Financial District, and it remains the country’s largest pharmaceutical and life sciences cluster through Genome Valley. Telangana’s single-window TS-iPASS clearance system and a deep engineering and life-sciences talent base have pulled in GCCs, deep-tech startups and pharma majors alike. If you are searching for an ESOP consultant in Hyderabad, this guide covers plan design, valuation, and regulatory compliance under the law as it stands from 1 April 2026.

1. The Hyderabad Business Context: Why ESOPs Matter Here

Hyderabad’s transformation from a legacy administrative and pharmaceutical centre into “Cyberabad” is now a mature story, but the pace of change has not slowed. HITEC City, Gachibowli, Madhapur and the Financial District together form one of India’s largest contiguous technology corridors, and the city now ranks among the top two Global Capability Centre hubs in the country, competing closely with Bengaluru for new setups. For any company operating in this environment, equity compensation is not an optional extra — it is the baseline expectation of the talent pool a Hyderabad employer is competing for. A well-structured plan requires the involvement of an experienced ESOP consultant in Hyderabad who understands both the statutory framework and the specific dynamics of the city’s dominant sectors.

1.1 A GCC and IT Hub Competing Directly for Talent

Hyderabad hosts several hundred Global Capability Centres employing well over 300,000 professionals across engineering, AI, cloud, cybersecurity and finance functions, with major technology, BFSI and life-sciences names operating large campuses across HITEC City, Gachibowli and the Financial District. GCCs increasingly bring equity-linked retention tools from their parent geographies into the Indian entity, and Indian technology and services companies competing for the same engineering and product talent pool cannot credibly compete on fixed salary alone. For a broader look at why this matters, see our guide on what an ESOP consultant does and why your business needs one.

1.2 India’s Largest Pharmaceutical and Life Sciences Cluster

Hyderabad is home to Genome Valley, one of the country’s largest integrated life sciences clusters, and the city accounts for a substantial share of India’s pharmaceutical and bulk drug production and vaccine manufacturing capacity. Pharmaceutical, biotech and contract research companies headquartered or expanding in Hyderabad face a different ESOP challenge from a typical SaaS startup: longer product and regulatory cycles, a smaller pool of specialised scientific and regulatory talent, and a need for vesting structures that reward multi-year retention through clinical, regulatory and manufacturing milestones rather than short sprint cycles.

1.3 A State Government Actively Backing Startups

1.4 Aerospace, Defence and Deep-Tech

Hyderabad has also built a genuine aerospace and defence manufacturing base, and is home to a number of private space-tech and deep-tech ventures. These companies typically combine long capital-intensive development cycles with a small, highly specialised engineering workforce, making equity retention tools especially important for holding onto scarce technical talent through pre-revenue and early-revenue stages. For guidance on structuring plans at this stage, see: How ESOP consultants help startups design effective ESOP plans.

2. What Makes Hyderabad Different: Sector-Specific ESOP Considerations

A generic ESOP template built for a Bengaluru SaaS company will not fit a Genome Valley biotech firm, a HITEC City GCC, or a Hyderabad-based defence manufacturer equally well. A competent ESOP consultant in Hyderabad needs to be fluent across each of the city’s principal industry clusters.

2.1 Information Technology, GCCs and SaaS

• Standard ESOP pool sizing: Technology and SaaS companies operating out of HITEC City and Gachibowli typically reserve 10 to 15 percent of fully diluted equity for the ESOP pool prior to Series A, broadly consistent with national norms.
• Competing with GCC compensation structures: Indian product and services companies competing for the same engineering talent as large multinational GCCs need a credible equity story, since GCCs often bring RSU or parent-company stock programmes to the local market.
• Eligible start-up benefit: Start-ups headquartered in Hyderabad that hold both DPIIT recognition and an Inter-Ministerial Board certificate under Section 140 of the Income-tax Act, 2025 (the successor to Section 80-IAC of the 1961 Act) can offer employees deferred perquisite taxation. See our complete guide: Taxes on ESOPs for Startups in India.

2.2 Pharmaceuticals, Biotech and Life Sciences

• Longer vesting horizons: Given multi-year drug development, clinical trial and regulatory approval cycles, pharma and biotech ESOP schemes often use longer vesting periods or milestone-linked vesting tied to regulatory or manufacturing achievements rather than a standard four-year time-based schedule alone.
• Retaining scientific and regulatory talent: Specialist roles in formulation science, regulatory affairs and clinical operations are in short supply even within Hyderabad’s deep life-sciences base; ESOPs are an important lever alongside cash compensation for retaining this talent.
• Capital-intensive balance sheets: Where a NAV-based valuation approach is used for these companies, plant, machinery, and manufacturing infrastructure often form a significant share of net assets, which affects the FMV computation for exercise-date purposes.

2.3 Global Capability Centres (GCCs)

• Parent-linked equity vs. local ESOPs: Many GCCs in Hyderabad extend RSUs or stock options in the foreign parent entity rather than issuing shares of the Indian subsidiary. This route carries its own compliance layer, including FEMA reporting on the acquisition of foreign securities by resident employees, separate from a standard domestic ESOP under the Companies Act, 2013.
• 409A-linked valuations: Where a GCC’s US parent requires an Indian valuation input to support its own 409A process, or where the Indian entity itself needs a comparable fair market value determination, this is distinct from an Indian statutory ESOP valuation. See: Can an Indian valuer do a 409A valuation?
• Retention-linked vesting for expansion-stage GCCs: As GCCs scale headcount rapidly in Hyderabad, retention-linked vesting structures for early local leadership hires are increasingly common ahead of larger organisational build-out.

2.4 Aerospace, Defence and Deep-Tech

• Pre-revenue equity retention: Long development cycles before commercial revenue make equity participation especially important for holding scarce specialist engineering talent through early-stage capital constraints.
• Smaller, concentrated option pools: Given typically smaller founding and engineering teams relative to consumer-tech startups, pool sizing and individual grant sizing require careful cap-table modelling to avoid excessive early dilution.

Marcken Consulting’s valuation work is signed by an IBBI-registered Valuer (Securities or Financial Assets). Where a transaction also requires a Merchant Banker’s certificate, that certificate is issued by a SEBI-registered Category-I Merchant Banker within the same coordinated engagement — so the Companies Act and income-tax requirements of an ESOP are addressed together rather than through two separate processes.

3. The ESOP Lifecycle: A Stage-by-Stage Guide for Hyderabad Companies

Because Hyderabad’s economy runs on three distinct tracks — venture-funded startups, GCC subsidiaries of foreign parents, and established pharma or manufacturing groups — the ESOP journey does not follow a single template the way it might in a pure-startup hub. The table below maps the key ESOP actions and regulatory triggers against each stage, distinguishing the startup funding lifecycle from the GCC and pharma tracks that make up a large share of Hyderabad’s corporate base. For a comprehensive overview of when valuation is mandatory under Indian law, see: Valuation Applicability in India.

Company Stage / Track	ESOP Actions Required	Regulatory / Compliance Trigger
Startup — Pre-Seed / Seed	Founder grants, ESOP pool creation (5–10%), DPIIT recognition planning	Section 62(1)(b) allotment; DPIIT recognition; Section 140 / IMB certificate (Income-tax Act, 2025) for ESOP tax deferral
Startup — Series A / B	Key-hire grants, pool top-up to 10–15% fully diluted, vesting schedule design	Ind AS 102 grant-date fair value; RV/MB valuation for exercise price setting
Startup — Growth / Series C+	Performance and milestone-linked vesting, ESOP buyback, secondary liquidity for early employees	Rule 15 Merchant Banker certificate on each exercise date; TDS on perquisite income
GCC — New Setup / Ramp-up	Decision on parent-linked equity (foreign RSUs) vs. a local ESOP scheme for the Indian entity; leadership retention grants	FEMA reporting on receipt of foreign securities if parent-linked; Section 62(1)(b) if local scheme is chosen
GCC — Steady-State Operations	Periodic FMV certification for any local grants; coordination with parent’s global equity plan calendar	Rule 15 Merchant Banker certificate on exercise; annual Board disclosure under Rule 12(9)
Pharma / Manufacturing — Established Company	Milestone-linked vesting tied to regulatory approvals or plant commissioning; NAV-based exercise price given asset-heavy balance sheets	NAV computation under Rule 57 informs valuation inputs; Rule 15 MB certificate for perquisite FMV
Pre-IPO (any track)	ESOP scheme alignment with SEBI SBEB Regulations, trust structure, exchange disclosure	SEBI compliance from listing date; independent registered valuer required for SBEB valuations from 2 January 2026
Post-IPO / Exit (any track)	RSU/SAR conversion, accelerated vesting on change of control, employee liquidity event	Capital gains tax planning; SEBI LODR disclosures; open offer valuation if applicable

The table illustrates why ESOP advisory in Hyderabad cannot be a one-size-fits-all engagement. A venture-funded SaaS startup in HITEC City moves through the top three rows in a matter of years; a GCC’s Indian entity may sit in the “steady-state” row for a decade while its US or European parent handles most equity compensation; and a pharma manufacturer may only touch the ESOP framework once, at a single significant liquidity or listing event. An experienced ESOP consultant in Hyderabad needs to recognise which track a client is on before recommending a plan design.

4. Listed vs. Unlisted Companies: The Regulatory Framework

The compliance framework, tax treatment, and valuation methodology differ depending on whether the company is listed or unlisted. Nearly all Hyderabad-based startups and GCC subsidiaries fall into the unlisted category at the ESOP-implementation stage, but the listed framework becomes directly relevant as companies approach an IPO.

4.1 ESOPs for Listed Companies

Listed companies must comply with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (the SBEB Regulations). Key requirements include:

• Board and Shareholder Approval: A special resolution is required before any ESOP scheme is adopted or amended.
• SEBI Disclosure Norms: The Board’s report must disclose the scheme particulars specified in Part F of Schedule I to the SBEB Regulations, along with a secretarial auditor’s certificate confirming implementation in accordance with the Regulations, placed before shareholders at each AGM.
• Independent Trustee Structure: ESOPs implemented through a trust route require an independent trustee and a trust deed.
• Valuation — updated position from January 2026: By the SEBI (Share Based Employee Benefits and Sweat Equity) (Second Amendment) Regulations, 2025 — Notification No. SEBI/LAD-NRO/GN/2025/284 dated 3 December 2025 — Regulation 34(1) of the SBEB Regulations now requires valuations under those Regulations to be carried out by an independent registered valuer rather than a Merchant Banker, aligning the definition of “valuer” with Section 247 of the Companies Act, 2013. A Merchant Banker may complete only assignments already undertaken before that date, within nine months from 2 January 2026.

4.2 ESOPs for Unlisted / Private Companies

Unlisted companies — from early-stage Hyderabad startups to established pharma and engineering firms — are governed by Section 62(1)(b) of the Companies Act, 2013 read with Rule 12 of the Companies (Share Capital and Debentures) Rules, 2014. Key requirements include:

• Shareholder Approval: A special resolution is required for a public company. Private companies may pass an ordinary resolution under MCA exemption notification G.S.R. 464(E) dated 5 June 2015, although Rule 12(1) has not been correspondingly amended, and many private companies still pass a special resolution as a matter of caution.
• ESOP Committee: Mandatory for listed companies under the SBEB Regulations; recommended but not mandatory under Rule 12 for private companies.
• Grant Letter and Vesting Schedule: Each grant must be documented with a formal grant letter specifying options, exercise price, vesting dates, and conditions.
• Valuation Certificate: Required from a Registered Valuer (RV) or Merchant Banker (MB) to determine fair value of shares for accounting and tax purposes. See: the difference between an IBBI Registered Valuer and SEBI Merchant Banker.
• ESOP perquisite valuation: For income-tax purposes, the perquisite is the fair market value (FMV) of the shares on the date of exercise less the exercise price paid. With effect from 1 April 2026, this is governed by Rule 15 of the Income-tax Rules, 2026 read with Section 17(1) of the Income-tax Act, 2025 — the successor provisions to Rule 3(8)/3(9) of the Income-tax Rules, 1962 and Section 17(2)(vi) of the Income-tax Act, 1961. For unlisted shares, the FMV must be certified by a SEBI-registered Category-I Merchant Banker. See our detailed post on valuation applicability under Indian law.

5. What Does an ESOP Consultant in Hyderabad Actually Do?

ESOP implementation is frequently mistaken for a one-time documentation exercise. In reality it is a multi-phase engagement spanning plan design, legal documentation, regulatory filings, valuation, accounting, and ongoing compliance. For a broader view, read our post on what an ESOP consultant does and why your business needs one.

5.1 Phase 1 — Plan Design

• Eligibility Matrix: Determining which categories of employees — permanent, contractual, directors, subsidiary employees — qualify under applicable law.
• Vesting Schedule: Cliff versus graded vesting; performance-linked versus time-based vesting; accelerated vesting on exit or, in pharma and deep-tech contexts, milestone-linked vesting tied to regulatory or product achievements.
• Exercise Price: Par value, fair market value, or discounted FMV — each carries different tax and accounting consequences.
• Option Pool Sizing: Calculating an appropriate ESOP pool as a percentage of fully diluted equity, factoring in anticipated future funding rounds.
• Plan Document Drafting: ESOP Scheme document, Trust Deed (if applicable), Grant Letters, Exercise Forms, and Board/Shareholder Resolutions.

5.2 Phase 2 — Regulatory Filings and Corporate Actions

• MCA Filings: Form PAS-3 for allotment, Form MGT-14 for resolutions, and other applicable ROC filings.
• SEBI Disclosures: For listed companies, disclosures to BSE / NSE within prescribed timelines.
• Secretarial Compliance: Board meeting minutes, Compensation Committee minutes (where constituted), and ESOP register maintenance.

5.3 Phase 3 — Valuation

• Fair Value for Accounting: Ind AS 102 requires options to be measured at grant-date fair value using Black-Scholes or binomial models. See: how ESOP valuation is calculated.
• FMV for Tax (Rule 15, IT Rules 2026): The FMV at exercise date determines the perquisite income taxable in the employee’s hands. See also: Income Tax vs. Companies Act valuation — what is the difference?
• Merchant Banker / RV Certificate: Formal valuation report signed by a SEBI-registered Merchant Banker or IBBI-registered Valuer as required for the specific transaction.

5.4 Phase 4 — Ongoing Compliance

• Annual Disclosures: Filing requirements under the SBEB Regulations (listed) and Companies Act (unlisted).
• Buyback and Liquidity Events: Advising on secondary sales, buyback of vested options, and employee liquidity at funding or exit events.
• Modifications and Amendments: Repricing of options, acceleration clauses, and scheme amendments on corporate restructuring.

6. The ESOP Implementation Roadmap for Hyderabad Companies

The statutory process for implementing an ESOP is set out in the Companies Act, 2013 and applies uniformly across India. The roadmap below sets out how this typically plays out for a Hyderabad private limited company.

Step 1 — Feasibility and Design (Weeks 1 to 2)

• Cap table analysis: Review existing shareholding, identify promoter dilution threshold, and size the ESOP pool on a fully diluted basis.
• Instrument selection: Determine whether ESOPs, RSUs, SARs, or a combination best serves the company’s objectives. See: ESOP consultants vs. valuers — key differences.
• Vesting structure: Design vesting schedule — cliff period, graded vesting, performance conditions, and acceleration triggers.
• Exercise price determination: Set exercise price based on current fair market value; obtain MB or RV valuation certificate as applicable.

Step 2 — Documentation (Weeks 2 to 4)

• ESOP Scheme document: Comprehensive plan document governing eligibility, vesting, exercise, and lapse conditions.
• Board resolution: Board approval for adoption of the scheme, and, where constituted, a Compensation Committee to administer it.
• Shareholder resolution: By special resolution for a public company; by ordinary resolution for a private company under MCA exemption notification G.S.R. 464(E) dated 5 June 2015, subject to the caution noted above.
• Grant letters: Individual grant letters to each optionee specifying option count, exercise price, vesting schedule and conditions.

Step 3 — Regulatory Filings (Weeks 4 to 6)

• Form MGT-14: Filing of the special resolution with the MCA within 30 days of passing.
• SEBI disclosures: For listed companies, intimation to BSE / NSE and Board report disclosure as specified in Part F of Schedule I to the SBEB Regulations. Note that, from 2 January 2026, valuations under the SBEB Regulations must be carried out by an independent registered valuer.
• Trust registration: If the trust route is adopted, registration of the ESOP trust with the relevant Sub-Registrar.

Step 4 — Valuation and Accounting (Ongoing)

• Ind AS 102 accounting: Grant-date fair value computed using the Black-Scholes model, recognised as employee benefit expense over the vesting period.
• Rule 15 certificate: Merchant Banker valuation certificate obtained for each exercise date for income-tax compliance, dated within 180 days of the exercise date.
• Annual disclosures: Board report disclosures under Rule 12(9) of the Companies (Share Capital and Debentures) Rules, 2014.

Step 5 — Exercise and Allotment

• Exercise notice: Employee submits exercise form with payment of exercise price.
• Board allotment: Board approves allotment of shares; share certificates or demat credit issued.
• Form PAS-3: Filing of return of allotment with MCA within 30 days.
• Perquisite computation: Company deducts TDS on perquisite income (FMV at exercise minus exercise price) via Form 16 / Form 12BA to the Income Tax Department, under Section 392 of the Income-tax Act, 2025.

7. ESOP Valuation: The Technical Core

Valuation is the most technically demanding component of an ESOP engagement. Getting the numbers wrong can trigger tax demands on employees, accounting restatements, or regulatory scrutiny. There are three distinct valuation requirements a company will encounter.

7.1 Ind AS 102 — Grant-Date Fair Value (Accounting)

Under Ind AS 102, every option grant must be measured at fair value on the grant date using an option-pricing model. Marcken Consulting uses the Black-Scholes-Merton model, with inputs calibrated to Indian market conditions:

• Underlying share price — derived from a DCF / NAV / CCM analysis for unlisted companies, or the exchange closing price for listed companies.
• Exercise price — as specified in the grant letter.
• Expected term — adjusted for early exercise behaviour; typically the mid-point between vesting and expiry.
• Expected volatility — historical volatility for listed companies; peer-group proxy volatility for unlisted companies.
• Risk-free rate — based on government securities of matching tenor.
• Expected dividend yield — based on dividend history, or zero for growth-stage companies.

7.2 Rule 15, Income-tax Rules 2026 — FMV at Exercise Date (Income Tax)

With effect from 1 April 2026, Rule 15 of the Income-tax Rules, 2026 governs perquisite valuation under Section 17(1) of the Income-tax Act, 2025. Where, on the date of exercise, the shares are not listed on a recognised stock exchange in India, the FMV is determined by a Category-I Merchant Banker registered with SEBI, on the exercise date or on an earlier date not more than 180 days before it. The Rule does not prescribe a valuation method: the Merchant Banker applies DCF, NAV, or a market-based approach according to the facts of the company.

A point of frequent confusion is worth stating plainly. The Net Asset Value formula at Sl. No. 4 of Rule 57 of the Income-tax Rules, 2026 (the successor to Rule 11UA(1)(c)(b) of the 1962 Rules) governs the FMV of unquoted equity shares for the purposes of Section 92(2)(m) and Section 79 of the Income-tax Act, 2025 (the successors to Section 56(2)(x) and Section 50CA of the 1961 Act). It is not the rule that governs the ESOP perquisite. The ESOP perquisite is governed by Rule 15.

This certification feeds directly into the Merchant Banker valuation report issued for income-tax purposes. For a practical comparison of the Indian NAV framework with the US equivalent, see our post on Rule 11UA vs. 409A Valuation.

7.3 409A-Equivalent Valuation (for GCCs and US-Linked Entities)

Given Hyderabad’s concentration of Global Capability Centres and US-founded technology and life-sciences companies, Indian subsidiaries frequently require a 409A-equivalent valuation — a fair market value determination of the Indian company’s common shares used to set strike prices for US tax purposes, or to support the US parent’s own 409A process. Marcken Consulting has experience producing 409A-compliant valuation reports using Weighted Average Value (WAV) methodology across DCF, NAV, and Comparable Company Multiple (CCM) approaches. Read our complete guide: Can an Indian valuer do a 409A valuation?

8. Why Hire a SEBI-Registered Merchant Banker for ESOP Valuation?

Rule 15 of the Income-tax Rules, 2026 requires that the FMV of unlisted shares on ESOP exercise be certified by a SEBI-registered Category-I Merchant Banker. A Chartered Accountant’s valuation does not satisfy this requirement, and a certificate that does not meet the Rule exposes the company to a TDS shortfall and the employee to reassessment. For a broader look at when a Registered Valuer is required at each funding stage, see our companion guide: Registered Valuer in Hyderabad.

For a detailed explanation of the difference between the two credentials, refer to: What is the difference between an IBBI Registered Valuer and a SEBI Merchant Banker? For a broader picture of who is authorised to issue valuation reports in India, see: Who Can Issue a Business Valuation Report in India?

9. Common ESOP Mistakes and How an Expert Avoids Them

• Incorrect option pool calculation: Creating a pool without accounting for the fully diluted cap table leads to surprise dilution at the next funding round.
• Missing shareholder resolutions: An ESOP scheme adopted without the shareholder approval required by Section 62(1)(b) and Rule 12 is a compliance defect that can render grants unenforceable and expose the company and its directors to penalty. Obtain the resolution before any grant is made.
• Using book value as FMV: Book value and FMV are entirely different concepts. Using book value to set the exercise price understates the perquisite tax base incorrectly and creates downstream tax exposure.
• Ind AS 102 non-compliance: Forgetting to expense the grant-date fair value of options through the P&L results in an audit qualification and potential financial restatement.
• Citing repealed law: A valuation or compliance document that cites Rule 3(8) or Section 17(2)(vi) for a transaction dated on or after 1 April 2026 is citing repealed law. The operative references are Rule 15 and Section 17(1) of the Income-tax Act, 2025.
• Ignoring the 180-day window: The Merchant Banker certificate must be dated on the exercise date or not more than 180 days before it; a stale certificate creates tax litigation risk.

10. Working with Marcken Consulting as Your ESOP Consultant in Hyderabad

Marcken Consulting LLP is an Ahmedabad-headquartered CA firm providing end-to-end ESOP advisory, valuation, and compliance services to companies across India, including Hyderabad’s GCC, IT, pharma and deep-tech ecosystem. The firm’s approach is set out below.

• Coordinated Credential Coverage: Valuation reports are signed by an IBBI-registered Registered Valuer (Securities or Financial Assets). Where a transaction also requires a Merchant Banker’s certificate, that certificate is issued by a SEBI-registered Category-I Merchant Banker within the same coordinated engagement, covering both the company-level and tax-level requirements.
• Sector Fluency: Experience spanning GCC subsidiaries, IT and SaaS startups, pharmaceutical and life-sciences companies, and deep-tech ventures — the principal sectors that define Hyderabad’s economy. Read about the key difference between ESOP consultants and valuers.
• Full-Cycle Delivery: Plan design, scheme drafting, corporate resolutions, ROC filings, Ind AS 102 valuation, Rule 15 Merchant Banker certificate, and ongoing compliance — all under one roof.
• Technology-Driven Precision: Proprietary Excel-based valuation models with full formula transparency; clients receive editable working files rather than opaque black boxes.
• Cross-Border Capability: Experience in 409A-equivalent valuations for US-founded companies and GCCs with Indian subsidiaries. See: When is a 409A valuation compulsory?
• Current on the Law: All engagements reflect the Income-tax Act, 2025 and Income-tax Rules, 2026 as applicable from 1 April 2026, and the SEBI amendments effective 2 January 2026.

11. Frequently Asked Questions — ESOP Consultant in Hyderabad

Q1. How much does an ESOP consultant in Hyderabad charge?

A: Fees depend on the scope of services. A standalone Merchant Banker valuation certificate for Rule 15 purposes typically starts at a flat professional fee. A comprehensive ESOP design and implementation engagement — including scheme drafting, resolutions, ROC filings, Ind AS 102 accounting, and MB certificate — is priced based on company size and complexity. For a general sense of valuation fees in India, see our post on what a company valuer charges for a valuation. Contact Marcken Consulting for a tailored quote.

Q2. Is an ESOP valuation mandatory every year?

A: For income-tax purposes, a fresh FMV determination is required each time employees exercise their options. For Ind AS 102 accounting, the grant-date fair value of an equity-settled option is measured once at grant and is not subsequently remeasured, although the estimate of the number of options expected to vest is revised at each reporting date. Cash-settled awards such as SARs are remeasured at each reporting date. Listed companies may also need periodic valuations for SEBI disclosure purposes. See our comprehensive overview: Valuation Applicability in India.

Q3. Can a Hyderabad GCC offer equity linked to its foreign parent instead of local shares?

A: Yes. Many GCCs operating out of HITEC City, Gachibowli and the Financial District extend RSUs or stock options in the foreign parent company rather than issuing shares of the Indian subsidiary. This route carries its own compliance layer — including FEMA reporting on the acquisition of foreign securities by resident employees and specific perquisite valuation rules — that differs from a standard domestic ESOP under the Companies Act. It should be structured with specific reference to the parent entity’s plan documents rather than adapted from a generic Indian ESOP template.

Q4. What is the difference between ESOPs, RSUs, and SARs?

A: An ESOP gives the right to buy shares at a fixed exercise price after vesting. An RSU (Restricted Stock Unit) vests into actual shares — or a cash equivalent — upon satisfaction of conditions, with no exercise price. A SAR (Stock Appreciation Right) pays out the appreciation in share value in cash, without any actual share delivery. Each instrument has different accounting, tax, and dilution implications. For a detailed comparison, see our guide: Ownership to Appreciation: ESOP and SAR Valuation.

Q5. Which law governs ESOPs for a private limited company in Hyderabad?

A: Section 62(1)(b) of the Companies Act, 2013 read with Rule 12 of the Companies (Share Capital and Debentures) Rules, 2014 — this applies uniformly across India and does not vary by state. For income-tax purposes, the perquisite is governed by Section 17(1) of the Income-tax Act, 2025 (with effect from 1 April 2026), and the FMV on exercise is determined under Rule 15 of the Income-tax Rules, 2026. For a full breakdown of sections requiring valuation, see: Income Tax Act sections requiring valuation reports.

Q6. What are the tax implications of ESOPs for employees in Hyderabad?

A: ESOP taxation occurs at two stages: first, at exercise — the difference between FMV and exercise price is treated as a perquisite under Section 17(1) of the Income-tax Act, 2025 and taxed as salary income; second, at sale — the gain from sale over the FMV at exercise is taxed as capital gains (short-term or long-term depending on the holding period). For eligible start-ups — those holding both DPIIT recognition and an Inter-Ministerial Board certificate under Section 140 of the Income-tax Act, 2025 — the perquisite tax at exercise may be deferred to the earliest of sale of the shares, cessation of employment, or 48 months from the end of the relevant tax year in which the shares were allotted. For a complete guide, see our post: Taxes on ESOPs for Startups in India.

Q7. Does Hyderabad’s TS-iPASS single-window system affect ESOP compliance?

A: Not directly. TS-iPASS governs industrial and business setup approvals — land, power, environmental and building clearances — under the Telangana State Industrial Project Approval and Self-Certification System Act, 2014. ESOP compliance is governed by the Companies Act, 2013, Ind AS 102, and the Income-tax Act, 2025, all of which apply uniformly across India regardless of state-level industrial approval systems. TS-iPASS is, however, a useful indicator of how quickly a Hyderabad-based company can move from incorporation to operational scale — and, in turn, how soon it is likely to need a properly structured ESOP pool for hiring.

Q8. Does Marcken Consulting also handle ESOP buybacks and secondary transactions?

A: Yes. Marcken Consulting advises on employee liquidity events including company-led buybacks of vested options, secondary share sales to incoming investors, and structuring of exit-linked acceleration clauses, and issues the valuation certificates required in connection with such transactions. See our related post on 409A valuation vs. investor valuation for context on how valuation differs across corporate events.

12. Ready to Implement or Audit Your ESOP? Contact Us

Whether you are a HITEC City startup designing your first ESOP scheme, a Genome Valley pharma company structuring milestone-linked vesting, a GCC evaluating parent-linked equity versus a local plan, or a company preparing for an IPO, Marcken Consulting is equipped to assist. Related ESOP guides by city: ESOP Consultant in Mumbai, Ahmedabad, Bengaluru, Delhi, and Kolkata.

Reach out to us at: marckenconsulting.com
Marcken Consulting LLP — IBBI-Registered Valuer (Securities or Financial Assets) | Ahmedabad
Phone: +91 99980 59923 / +91 99985 39902
Email: crm@marckenconsulting.com

---

Disclaimer: This article is intended for general informational purposes only and does not constitute legal, tax, or financial advice. Readers are advised to consult a qualified professional before acting on any information contained herein. Regulations referred to above are subject to amendment; please verify the current position at the time of acting.